A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., Wilding, J. P. H., Smith, D. M., Ghatei, M. A., Herbert, J., Bloom, S. R·1996·Nature
DOI 10.1038/379069a0

Cited by (198)

Items 101–198 of 198

  1. Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization
    Jensen, Casper Bo, Pyke, Charles, Rasch, Morten Grønbech, Dahl, Anders Bjorholm, Knudsen, Lotte Bjerre, Secher, Anna · 2018 · Endocrinology
  2. Learning one’s genetic risk changes physiology independent of actual genetic risk
    Turnwald, Bradley P., Goyer, J. Parker, Boles, Danielle Z., Silder, Amy, Delp, Scott L., Crum, Alia J. · 2018 · Nature Human Behaviour
  3. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans
    Schirra, J, Houck, P, Wank, U, Arnold, R, Göke, B, Katschinski, M · 2000 · Gut
  4. The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
    Madsbad, S. · 2014 · Diabetes, Obesity and Metabolism
  5. Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents
    Gallwitz, Baptist · 2011 · Drugs
  6. Neural contribution to the effect of glucagon-like peptide-1-(7—36) amide on arterial blood pressure in rats
    Barragán, José Manuel, Eng, John, Rodríguez, Raquel, Blázquez, Enrique · 1999 · American Journal of Physiology-Endocrinology and Metabolism
  7. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
    Sørensen, Gunnar, Reddy, India A., Weikop, Pia, Graham, Devon L., Stanwood, Gregg D., Wortwein, Gitta, Galli, Aurelio, Fink-Jensen, Anders · 2015 · Physiology & Behavior
  8. Gut Microbiota in Obesity and Undernutrition
    de Clercq, Nicolien C, Groen, Albert K, Romijn, Johannes A, Nieuwdorp, Max · 2016 · Advances in Nutrition
  9. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
    Kooijman, Sander, Wang, Yanan, Parlevliet, Edwin T., Boon, Mariëtte R., Edelschaap, David, Snaterse, Gido, Pijl, Hanno, Romijn, Johannes A., Rensen, Patrick C. N. · 2015 · Diabetologia
  10. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice
    Burmeister, Melissa A., Ayala, Jennifer E., Smouse, Hannah, Landivar-Rocha, Adriana, Brown, Jacob D., Drucker, Daniel J., Stoffers, Doris A., Sandoval, Darleen A., Seeley, Randy J., Ayala, Julio E. · 2017 · Diabetes
  11. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.
    Beak, S A, Heath, M M, Small, C J, Morgan, D G, Ghatei, M A, Taylor, A D, Buckingham, J C, Bloom, S R, Smith, D M · 1998 · Journal of Clinical Investigation
  12. Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
    Apovian, Caroline M., Bergenstal, Richard M., Cuddihy, Robert M., Qu, Yongming, Lenox, Sheila, Lewis, Michelle S., Glass, Leonard C. · 2010 · The American Journal of Medicine
  13. GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats
    Fortin, Samantha M., Lipsky, Rachele K., Lhamo, Rinzin, Chen, Jack, Kim, Eun, Borner, Tito, Schmidt, Heath D., Hayes, Matthew R. · 2020 · Science Translational Medicine
  14. New targets to treat obesity and the metabolic syndrome
    Martin, Kathleen A., Mani, Mitra V., Mani, Arya · 2015 · European Journal of Pharmacology
  15. Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling ,
    Ronveaux, Charlotte C, Tomé, Daniel, Raybould, Helen E · 2015 · The Journal of Nutrition
  16. Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight
    Gaykema, Ronald P., Newmyer, Brandon A., Ottolini, Matteo, Raje, Vidisha, Warthen, Daniel M., Lambeth, Philip S., Niccum, Maria, Yao, Ting, Huang, Yiru, Schulman, Ira G. et al. · 2017 · Journal of Clinical Investigation
  17. GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
    Holst, Jens Juul · 2024 · Nature Metabolism
  18. Incretins: their physiology and application in the treatment of diabetes mellitus
    Tasyurek, Hale M., Altunbas, Hasan Ali, Balci, Mustafa Kemal, Sanlioglu, Salih · 2014 · Diabetes/Metabolism Research and Reviews
  19. Central administration of GLP-1 and GIP decreases feeding in mice
    NamKoong, Cherl, Kim, Min Sun, Jang, Byeong-Tak, Lee, Young Hee, Cho, Young-Min, Choi, Hyung Jin · 2017 · Biochemical and Biophysical Research Communications
  20. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala
    Parker, J A, McCullough, K A, Field, B C T, Minnion, J S, Martin, N M, Ghatei, M A, Bloom, S R · 2013 · International Journal of Obesity
  21. The neuroprotective effects of GLP-1: Possible treatments for cognitive deficits in individuals with mood disorders
    McIntyre, Roger S., Powell, Alissa M., Kaidanovich-Beilin, Oksana, Soczynska, Joanna K., Alsuwaidan, Mohammad, Woldeyohannes, Hanna O., Kim, Ashley S., Gallaugher, L. Ashley · 2013 · Behavioural Brain Research
  22. Alleviation of depression by glucagon-like peptide 1 through the regulation of Neuroinflammation, neurotransmitters, neurogenesis, and synaptic function
    Kim, Young-Kook, Kim, Oh Yoen, Song, Juhyun · 2020 · Frontiers in Pharmacology
  23. Sex and estrogens alter the action of glucagon-like peptide-1 on reward
    Richard, Jennifer E., Anderberg, Rozita H., López-Ferreras, Lorena, Olandersson, Kajsa, Skibicka, Karolina P. · 2016 · Biology of Sex Differences
  24. Exposure-response analyses of liraglutide 3.0 mg for weight management
    Wilding, J. P. H., Overgaard, R. V., Jacobsen, L. V., Jensen, C. B., le Roux, C. W. · 2016 · Diabetes, Obesity and Metabolism
  25. Changes in gut hormones after bariatric surgery
    Vincent, R. P., Le Roux, C. W. · 2008 · Clinical Endocrinology
  26. Glucagon-like peptides 1 and 2 in health and disease: A review
    Marathe, Chinmay S., Rayner, Christopher K., Jones, Karen L., Horowitz, Michael · 2013 · Peptides
  27. GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats
    Outeiriño-Iglesias, Verónica, Romaní-Pérez, Marina, González-Matías, Lucas C., Vigo, Eva, Mallo, Federico · 2015 · Endocrinology
  28. Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake
    Singh, Ishnoor, Wang, Le, Xia, Baijuan, Liu, Ji, Tahiri, Azeddine, El Ouaamari, Abdelfattah, Wheeler, Michael B., Pang, Zhiping P. · 2022 · Cell & Bioscience
  29. Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System
    Cheng, Carrie Yuen Yee, Chu, Jessica Yan Shuen, Chow, Billy Kwok Chong · 2011 · Neuropsychopharmacology
  30. GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
    Parlevliet, Edwin T., Wang, Yanan, Geerling, Janine J., Schröder-Van der Elst, Janny P., Picha, Kristen, O'Neil, Karyn, Stojanovic-Susulic, Vedrana, Ort, Tatiana, Havekes, Louis M., Romijn, Johannes A. et al. · 2012 · PLoS ONE
  31. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
    Nauck, M. A. · 1998 · Acta Diabetologica
  32. GLP-1/GLP-1R signaling in regulation of adipocyte differentiation and lipogenesis
    Chen, Jicui, Zhao, Huichen, Ma, Xiaoli, Zhang, Yuchao, Lu, Sumei, Wang, Yangang, Zong, Chen, Qin, Dandan, Wang, Yuanmei, Yingfeng Yang, Yingfeng et al. · 2017 · Cellular Physiology and Biochemistry
  33. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice
    Scrocchi, Louise A., Drucker, Daniel J. · 1998 · Endocrinology
  34. Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating
    Brierley, Daniel I., de Lartigue, Guillaume · 2022 · British Journal of Pharmacology
  35. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
    Tan, Tricia, Behary, Preeshila, Tharakan, George, Minnion, James, Al-Najim, Werd, Albrechtsen, Nicolai J. Wewer, Holst, Jens J., Bloom, Stephen R. · 2017 · The Journal of Clinical Endocrinology & Metabolism
  36. Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production
    Yang, Clair S., Lam, Carol K.L., Chari, Madhu, Cheung, Grace W.C., Kokorovic, Andrea, Gao, Sun, Leclerc, Isabelle, Rutter, Guy A., Lam, Tony K.T. · 2010 · Diabetes
  37. GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight
    Vogel, Heike, Wolf, Stefanie, Rabasa, Cristina, Rodriguez-Pacheco, Francisca, Babaei, Carina S., Stöber, Franziska, Goldschmidt, Jürgen, DiMarchi, Richard D., Finan, Brian, Tschöp, Matthias H. et al. · 2016 · Neuropharmacology
  38. Obesity and the kidney: mechanistic links and therapeutic advances
    Yau, Kevin, Kuah, Rachel, Cherney, David Z. I., Lam, Tony K. T. · 2024 · Nature Reviews Endocrinology
  39. Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
    McLean, Brent A., Wong, Chi Kin, Kaur, Kiran Deep, Seeley, Randy J., Drucker, Daniel J. · 2021 · JCI Insight
  40. Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
    Diz-Chaves, Yolanda, Herrera-Pérez, Salvador, González-Matías, Lucas C., Lamas, José Antonio, Mallo, Federico · 2020 · Nutrients
  41. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
    Jerlhag, Elisabet · 2023 · Frontiers in Pharmacology
  42. Striking the balance: GLP-1/glucagon co-agonism as a treatment strategy for obesity
    Hope, David C. D., Vincent, Matthew L., Tan, Tricia M. M. · 2021 · Frontiers in Endocrinology
  43. Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia
    Green, Charlotte J., Henriksen, Tora I., Pedersen, Bente K., Solomon, Thomas P. J. · 2012 · PLoS ONE
  44. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake
    McKay, Naomi J., Kanoski, Scott E., Hayes, Matthew R., Daniels, Derek · 2011 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  45. Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4
    Baraboi, Elena-Dana, St-Pierre, David H., Shooner, Julie, Timofeeva, Elena, Richard, Denis · 2011 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  46. The incretin/glucagon system as a target for pharmacotherapy of obesity
    Del Prato, Stefano, Gallwitz, Baptist, Holst, Jens Juul, Meier, Juris J. · 2022 · Obesity Reviews
  47. Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop
    Mathi, Swarna K., Chan, Yvonne, Li, Xinfang, Wheeler, Michael B. · 1997 · Molecular Endocrinology
  48. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose
    Burmeister, Melissa A., Ayala, Jennifer, Drucker, Daniel J., Ayala, Julio E. · 2013 · American Journal of Physiology-Endocrinology and Metabolism
  49. Recent advances in understanding the role of glucagon-like peptide 1
    Reed, Josh, Bain, Stephen, Kanamarlapudi, Venkateswarlu · 2020 · F1000Research
  50. Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
    Liu, Celina, Carvalho, Andre, McIntyre, Roger · 2015 · CNS & Neurological Disorders - Drug Targets
  51. N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity
    Green, BD, Mooney, MH, Gault, VA, Irwin, N, Bailey, CJ, Harriott, P, Greer, B, O'Harte, FP, Flatt, PR · 2004 · Journal of Endocrinology
  52. Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males
    Jeibmann, A., Zahedi, S., Simoni, M., Nieschlag, E., Byrne, M. M. · 2005 · European Journal of Clinical Investigation
  53. GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
    Li, Qiu-Xuan, Gao, Han, Guo, Yue-Xin, Wang, Bo-Ya, Hua, Rong-xuan, Gao, Lei, Shang, Hong-Wei, Lu, Xin, Xu, Jing-Dong · 2021 · Frontiers in Endocrinology
  54. Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells
    Li, Zhu, Ni, Chang-Lin, Yao, Zhi, Chen, Li-Ming, Niu, Wen-Yan · 2014 · Metabolism
  55. Endogenous Glucagon-Like Peptide-1 Reduces Drinking Behavior and Is Differentially Engaged by Water and Food Intakes in Rats
    McKay, Naomi J., Galante, Daniela L., Daniels, Derek · 2014 · The Journal of Neuroscience
  56. Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhou, Qian, Lei, Xingxing, Fu, Shunlian, Liu, Pan, Long, Cong, Wang, Yanmei, Li, Zinan, Xie, Qian, Chen, Qiu · 2023 · Diabetology & Metabolic Syndrome
  57. Management of metabolic-associated fatty liver disease: The diabetology perspective
    Jeeyavudeen, Mohammad Sadiq, Khan, Shahanas KA, Fouda, Sherouk, Pappachan, Joseph M · 2023 · World Journal of Gastroenterology
  58. Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice
    Andersen, Daniel B, Grunddal, Kaare V, Pedersen, Jens, Kuhre, Rune E, Lund, Mari L, Holst, Jens J, Ørskov, Cathrine · 2021 · Endocrinology
  59. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1
    Jerlhag, Elisabet · 2020 · Brain Research
  60. Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy
    Johansen, Valdemar Brimnes Ingemann, Petersen, Jonas, Lund, Jens, Mathiesen, Cecilie Vad, Fenselau, Henning, Clemmensen, Christoffer · 2025 · Cell
  61. GLP-1 Suppresses Feeding Behaviors and Modulates Neuronal Electrophysiological Properties in Multiple Brain Regions
    Chen, Xin-Yi, Chen, Lei, Yang, Wu, Xie, An-Mu · 2021 · Frontiers in Molecular Neuroscience
  62. Effect of Glucagon-like Peptide-1 Receptor Antagonism on Appetite and Food Intake in Healthy Men
    Steinert, Robert E, Schirra, Joerg, Meyer-Gerspach, Anne C, Kienle, Philipp, Fischer, Heiko, Schulte, Felix, Goeke, Burkhard, Beglinger, Christoph · 2014 · The American Journal of Clinical Nutrition
  63. The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
    Sloop, Kyle W., Cox, Amy L., Wainscott, David B., White, Alex, Droz, Brian A., Stutsman, Cynthia, Showalter, Aaron D., Suter, Todd M., Dunbar, James D., Snider, Brandy M. et al. · 2024 · Science Translational Medicine
  64. Novel Glucagon-Like Peptide-1 (GLP-1) Analog (Val8)GLP-1 Results in Significant Improvements of Glucose Tolerance and Pancreatic β-Cell Function after 3-Week Daily Administration in Obese Diabetic (ob/ob) Mice
    Green, Brian D., Lavery, Kerry S., Irwin, Nigel, O’Harte, Finbarr P.M., Harriott, Patrick, Greer, Brett, Bailey, Clifford J., Flatt, Peter R. · 2006 · The Journal of Pharmacology and Experimental Therapeutics
  65. GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice
    Chen, Zijun, Deng, Xiaofei, Shi, Cuijie, Jing, Haiyang, Tian, Yu, Zhong, Jiafeng, Chen, Gaowei, Xu, Yunlong, Luo, Yixiao, Zhu, Yingjie · 2024 · Journal of Clinical Investigation
  66. Nutrition and l and K-enteroendocrine cells
    Gutierrez-Aguilar, Ruth, Woods, Stephen C · 2011 · Current Opinion in Endocrinology, Diabetes & Obesity
  67. Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment
    Neumiller, Joshua J. · 2011 · Clinical Therapeutics
  68. Intra-islet glucagon-like peptide 1
    Fava, Genevieve E., Dong, Emily W., Wu, Hongju · 2016 · Journal of Diabetes and its Complications
  69. Therapies for inter-relating diabetes and obesity – GLP-1 and obesity
    Iepsen, Eva W, Torekov, Signe S, Holst, Jens J · 2014 · Expert Opinion on Pharmacotherapy
  70. The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
    Andreasen, Christine R., Andersen, Andreas, Vilsbøll, Tina · 2023 · Diabetologia
  71. A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome
    Yamamoto, Hiroshi, Mori, Tsuyoshi, Tsuchihashi, Hiroshi, Akabori, Hiroya, Naito, Hiroyuki, Tani, Tohru · 2005 · Digestive Diseases and Sciences
  72. The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
    Finney, Alexandra C., Das, Sandeep, Kumar, Dhananjay, McKinney, M. Peyton, Cai, Bishuang, Yurdagul, Arif, Rom, Oren · 2023 · Frontiers in Cardiovascular Medicine
  73. Effects of nutrition on neuro-endocrine stress responses
    Rohleder, Nicolas, Kirschbaum, Clemens · 2007 · Current Opinion in Clinical Nutrition and Metabolic Care
  74. Glucagon‐Like Peptide‐1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats
    McKay, N. J., Daniels, D. · 2013 · Journal of Neuroendocrinology
  75. A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia
    Winzeler, Bettina, Sailer, Clara O., Coynel, David, Zanchi, Davide, Vogt, Deborah R., Urwyler, Sandrine A., Refardt, Julie, Christ-Crain, Mirjam · 2021 · Journal of Clinical Investigation
  76. Bowels control brain: gut hormones and obesity
    Bewick, Gavin A. · 2012 · Biochemia Medica
  77. Cracking the combination: Gut hormones for the treatment of obesity and diabetes
    Alexiadou, Kleopatra, Anyiam, Oluwaseun, Tan, Tricia · 2019 · Journal of Neuroendocrinology
  78. Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus
    Liu, Ting, Ji, Ren-Lei, Tao, Ya-Xiong · 2022 · Pharmacology & Therapeutics
  79. Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus
    Chagra, Samantha L., Zavala, Jaidee K., Hall, Mara V., Gosselink, Kristin L. · 2011 · Regulatory Peptides
  80. Gut hormones and appetite regulation
    Hong, So-hyeon, Choi, Kyung Mook · 2024 · Current Opinion in Endocrinology, Diabetes & Obesity
  81. Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
    Son, Jang Won, le Roux, Carel W, Blüher, Matthias, Nauck, Michael A, Lim, Soo · 2026 · Endocrine Reviews
  82. Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers
    Winzeler, Bettina, da Conceição, Ismael, Refardt, Julie, Sailer, Clara O., Dutilh, Gilles, Christ-Crain, Mirjam · 2020 · Endocrine
  83. Advances in GLP-1 treatment: focus on oral semaglutide
    Eliaschewitz, Freddy G., Canani, Luis Henrique · 2021 · Diabetology & Metabolic Syndrome
  84. Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions
    Hasib, Annie · 2020 · Clinical Medicine Insights: Endocrinology and Diabetes
  85. Mechanisms behind GLP-1 induced weight loss
    Larsen, Philip J · 2008 · The British Journal of Diabetes & Vascular Disease
  86. Hindbrain glucagon-like peptide-1 neurons track intake volume and contribute to injection stress-induced hypophagia in meal-entrained rats
    Kreisler, Alison D., Rinaman, Linda · 2016 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  87. GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice
    Décarie-Spain, Léa, Fisette, Alexandre, Zhu, Zhimeng, Yang, Bin, DiMarchi, Richard D., Tschöp, Matthias H., Finan, Brian, Fulton, Stephanie, Clemmensen, Christoffer · 2019 · Neuropharmacology
  88. GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
    Burcelin, Rémy, Gourdy, Pierre, Dalle, Stéphane · 2014 · Physiology
  89. Epidemiology of Obesity and Pharmacologic Treatment Options
    Shettar, Vignesh, Patel, Sarang, Kidambi, Srividya · 2017 · Nutrition in Clinical Practice
  90. Expression Levels of Genes Likely Involved in Glucose-sensing in the Obese Zucker Rat Brain
    Bogacka, Iwona, Roane, David S., Xi, Xiaochun, Zhou, Jun, Li, Bing, Ryan, Donna H., Martin, Roy J. · 2004 · Nutritional Neuroscience
  91. Recent progress in the pharmacotherapy for obesity
    Lu, Jiale, Liu, Pengfei, Cai, Mengyang, Lv, Tongzhe, Zhang, Mengdi, Yin, Kaili, Cheng, Jie, Zhang, Guo · 2025 · European Journal of Pharmacology
  92. Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model‐based approach
    Papathanasiou, Theodoros, Strathe, Anders, Agersø, Henrik, Lund, Trine Meldgaard, Overgaard, Rune Viig · 2020 · Diabetes, Obesity and Metabolism
  93. Slow and Steady Wins the Race: 25 Years Developing the GLP-1 Receptor as an Effective Target for Weight Loss
    Kumar, Nitya, D’Alessio, David A · 2022 · The Journal of Clinical Endocrinology & Metabolism
  94. Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
    McMorrow, Hayley E., Cohen, Andrew B., Lorch, Carolyn M., Hayes, Nikolas W., Fleps, Stefan W., Frydman, Joshua A., Xia, Jessica L., Samms, Ricardo J., Beutler, Lisa R. · 2025 · Journal of Clinical Investigation
  95. Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions
    Isbil-Buyukcoskun, Naciye, Gulec, Guldal · 2005 · Regulatory Peptides
  96. Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease
    Kugathasan, Luxcia, Aronson, Yarden, Sridhar, Vikas S., Ni, Huajing, Ouimet, Jean-Philippe, Limonte, Christine P., Sarma, Shohinee, Cherney, David Z. I. · 2025 · Expert Review of Clinical Immunology
  97. Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic
    Aulinger, Benedikt, D'Alessio, David · 2007 · Current Opinion in Endocrinology, Diabetes & Obesity
  98. Eating Behavior
    Blundell, John E., Finlayson, Graham, Halford, Jason C. G. · 2009 · Clinical Obesity in Adults and Children